PLK5 and non-small cell lung carcinoma: Accordingly, the present study applied immunohistochemistry (IHC) and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect PLK5 protein and mRNA expression, aiming to confirm its relationship with clinical characteristics and prognosis in NSCLC patients.